搜索
Edap Tms SA
EDAP添加自选
4.420USD
+0.250+6.00%
收盘 05/18, 16:00（美东）报价延迟15分钟
165.68M总市值
亏损市盈率 TTM
关于 Edap Tms SA 公司
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Edap Tms SA简介
公司代码EDAP
公司名称Edap Tms SA
上市日期Aug 01, 1997
CEORhodes (Ryan)
员工数量310
证券类型Depository Receipt
年结日Aug 01
公司地址4, rue du Dauphine
城市VAULX-EN-VELIN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家France
邮编69120
电话33472153150
网址https://focalone.com/fr/accueil/
公司代码EDAP
上市日期Aug 01, 1997
CEORhodes (Ryan)
Edap Tms SA公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
1.53M
+80.34%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.34M
+6.99%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
1.53M
+80.34%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.34M
+6.99%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
收入明细
单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2024
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 4月17日 周五
更新时间: 4月17日 周五
持股股东
股东类型
持股股东
持股股东
占比
Soleus Capital Management, L.P.
19.50%
Morgan Stanley & Co. International Plc
8.94%
Rhodes (Ryan)
4.09%
Willsey (Lance)
3.56%
Rock Springs Capital Management LP
3.43%
其他
60.48%
持股股东
持股股东
占比
Soleus Capital Management, L.P.
19.50%
Morgan Stanley & Co. International Plc
8.94%
Rhodes (Ryan)
4.09%
Willsey (Lance)
3.56%
Rock Springs Capital Management LP
3.43%
其他
60.48%
股东类型
持股股东
占比
Hedge Fund
23.72%
Individual Investor
9.85%
Research Firm
9.02%
Investment Advisor
6.03%
Investment Advisor/Hedge Fund
0.08%
Bank and Trust
0.01%
其他
51.29%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
70
14.62M
39.01%
-711.40K
2025Q4
67
13.87M
40.98%
--
2025Q3
75
13.87M
43.87%
-275.79K
2025Q2
87
14.15M
45.65%
-604.14K
2025Q1
89
14.75M
47.73%
-3.10M
2024Q4
92
15.39M
47.99%
-286.99K
2024Q3
91
15.67M
50.30%
-364.48K
2024Q2
88
16.06M
51.11%
-201.29K
2024Q1
93
16.22M
51.99%
-3.07M
2023Q4
90
15.98M
53.82%
-494.00
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Soleus Capital Management, L.P.
7.31M
19.5%
--
--
Dec 31, 2025
Morgan Stanley & Co. International Plc
3.35M
8.94%
-9.70K
-0.29%
Dec 31, 2025
Rhodes (Ryan)
301.15K
0.8%
+301.15K
--
Jan 01, 2026
Willsey (Lance)
1.24M
3.31%
+1.24M
--
Jan 01, 2026
Rock Springs Capital Management LP
1.29M
3.43%
+16.50K
+1.30%
Dec 31, 2025
Flax Pond Capital LLC
797.25K
2.13%
+797.25K
--
Dec 31, 2025
Mobeck (Kenneth S.)
56.61K
0.15%
+56.61K
--
Jan 01, 2026
Bruce & Company, Inc.
438.65K
1.17%
--
--
Dec 31, 2025
UBS Financial Services, Inc.
207.76K
0.55%
-26.69K
-11.38%
Dec 31, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
